ELANFIT s.r.o.
ActiveKey figures
Key figures
2025Dividends
calculatedDistributed as dividends 4 886 € (<1 % of distributable profit).
In addition, equity decreased by 25 076 € other than from retained earnings — e.g. a share capital reduction, a payout from other funds or a revaluation. The open data does not show whether this was a payout to shareholders.
Summary: ELANFIT s.r.o.
What kind of company is it?
ELANFIT s.r.o. (IČO 36279757) is a limited liability company (s.r.o.). The company was incorporated in 2006 and has existed for 20 years. Registered office according to the register: Gbely. Main activity according to the Statistical Office: maloobchod s farmaceutickými výrobkami (SK NACE 4773). Size category by number of employees: 3–4 employees.
Who runs the company and who owns it?
The statutory body has 3 members. According to the register, the company has one shareholder. The registered capital is 6 640 €.
How is the company doing financially?
Revenue for 2025 was 1 319 921 €, up 4,0 % on the previous year (1 268 807 €). From 2021 to 2025, revenue grew by an average of 7,2 % per year. This is the highest revenue in the reported years (2021–2025). Net profit for 2025 was 65 612 € (5,0 % of revenue). The company was profitable in all 5 reported years. Personnel costs for 2025 were 128 673 €. At the end of 2025 the company had total assets of 1 163 499 € and equity of 1 105 831 € (equity ratio 95,0 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 22. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 1 001 030 | 1 111 588 | 1 224 635 | 1 268 807 | 1 319 921 |
| Profit for the reporting year | 43 678 | 53 684 | 81 476 | 62 432 | 65 612 |
| Retained earnings of previous periods | 760 923 | 802 417 | 853 417 | 930 819 | 988 365 |
| Total assets | 923 320 | 958 829 | 1 054 263 | 1 177 087 | 1 163 499 |
| Total liabilities | 54 731 | 36 556 | 46 514 | 106 906 | 57 668 |
| Total equity | 868 589 | 922 273 | 1 007 749 | 1 070 181 | 1 105 831 |
| Calculated dividends | — | 0 | 0 | 0 | 4 886 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.
Documents in the Register of Financial Statements14
- 2025 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- INOVAX, s.r.o. · Nitra
- CORDATUM, s.r.o. · Dechtice
- Novozit, s.r.o. · Košice
- JULIANUS, s.r.o. · Kyselica
- LESTRUM, s.r.o. · Senica
- Alergo N+N, s.r.o. · Topoľčany
- Zdenpharm, s.r.o. · Nitra
- KARA med s.r.o. · Kopčany
- PHARMICA, spol. s r.o. · Piešťany
- Lekáreň DANUBIA s.r.o. · Košice